Elliot Norry insider trades: Adaptimmune Therapeutics (ADAP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Elliot reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | ADAP | ↓ Sell | 5,584 | $0.58 | $3K | Direct | Jan 17, 2025 (0d) |
| Jan 15, 2025 | ADAP | ↓ Sell | 22,195 | $0.58 | $13K | Direct | Jan 15, 2025 (0d) |
| Jan 17, 2024 | ADAP | ↓ Sell | 20,563 | $0.69 | $14K | Direct | Jan 17, 2024 (0d) |
| Jan 12, 2024 | ADAP | ↓ Sell | 11,808 | $0.85 | $10K | Direct | Jan 12, 2024 (0d) |
| Jan 17, 2023 | ADAP | ↓ Sell | 2,159 | $1.86 | $4K | Direct | Jan 17, 2023 (0d) |
| Jan 12, 2023 | ADAP | ↓ Sell | 11,292 | $1.72 | $19K | Direct | Jan 12, 2023 (0d) |
| Jan 4, 2023 | ADAP | ↓ Sell | 876 | $1.69 | $1K | Direct | Jan 4, 2023 (0d) |
| Jan 18, 2022 | ADAP | ↓ Sell | 2,121 | $3.19 | $7K | Direct | Jan 18, 2022 (0d) |
| Jan 12, 2022 | ADAP | ↓ Sell | 4,624 | $3.55 | $16K | Direct | Jan 13, 2022 (1d) |
| Jan 4, 2022 | ADAP | ↓ Sell | 849 | $4.06 | $3K | Direct | Jan 5, 2022 (1d) |
| Jan 19, 2021 | ADAP | ↓ Sell | 2,111 | $5.67 | $12K | Direct | Jan 19, 2021 (0d) |
| Jan 12, 2021 | ADAP | ↓ Sell | 841 | $6.15 | $5K | Direct | Jan 12, 2021 (0d) |
| Jan 4, 2021 | ADAP | ↓ Sell | 845 | $5.33 | $5K | Direct | Jan 5, 2021 (1d) |
| Jan 14, 2020 | ADAP | ↓ Sell | 911 | $5.13 | $5K | Direct | Jan 15, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Elliot Norry's insider trades
Elliot Norry is Chief Medical Officer at Adaptimmune Therapeutics (ADAP). Since Jan 14, 2020, Elliot has reported no open-market purchases and 14 sales worth $118K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADAP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.